Corporate Finance

Vator Securities focuses on identifying and financing growth companies as they expand and develop into tomorrow’s market leaders.

read more

About Us

Vator Securities executes on opportunities that accelerate growth for its client companies whilst delivering results to the firm’s sophisticated investor clientele.

read more

Vator Securities advises Gaming Corps on 32 MSEK Capital Raise

Gaming Corps AB is a development company that operates in the global digital gaming market by developing casino games and computer games in two business areas – iGaming and Gaming. The Company was founded in 2014 and has been listed on Nasdaq First North Growth Market since 2015.

The company works mainly with two business models, the first of which consists of the development of non-exclusive games that can be offered to more than one operator. The second business model relates to the development of tailor-made and/or exclusive games for individual operators, as well as various levels of branding and theme customization based on their needs.

read more

Vator Securities advises Moberg Pharma on 336 MSEK Capital Raise

Moberg Pharma AB (publ) is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The Company’s asset, MOB-015, is a novel topical treatment for onychomycosis with market approval in 13 EU countries.

MOB-015 is available in Sweden under the brand name Terclara®. Moberg Pharma has agreements with commercial partners in place in various regions including Europe and Canada.

read more

Vator Securities advises Magle Group in Acquisition of pK Biotech ApS and pK Chemicals

The Magle Group is founded on strategic acquisitions aimed at driving growth and diversifying risk. The Group includes two operational areas. Magle Chemoswed – a contract development and manufacturing organization (CDMO) with a strong reputation for its high-quality development and manufacturing expertise and Magle PharmaCept – an established sales and marketing company for development and direct sales of the Groups medical technology products.

pK Chemicals, headquartered in Denmark, is a leading player in the global pharmaceutical and medico sectors. Known for its production of technical Dextran and Dextran Derivatives, pK Chemicals has 65 employees and operates two manufacturing sites in Denmark. In 2023, pK Chemicals reported a gross profit of approximately SEK 116 million, with a profit from operating activities of approximately SEK 17 million.

read more

Listing of Tingsvalvet Fastighets AB on Nasdaq First North Growth Market

Vator Securities acts as the Listing Agent for Tingsvalvet Fastighets AB during the listing on Nasdaq First North Growth Market.

Tingsvalvet is a cash flow-driven real estate company focused on commercial properties with high yields, particularly in strong local locations in central Sweden. As of March 31, 2024, the property value amounted to approximately 1.9 billion SEK. The company acquires, refines, and develops high-yield commercial properties and owns easy-to-manage properties with strong cash flows and stable tenants. Tingsvalvet has a diversified property portfolio with an average contract length of 7.9 years.

read more

More News